We have many reasons to be excited by this report in this morning's VentureWire Lifescience about Nerites Corp. hiring its first CFO, former NimbleGen Systems Inc. exec David Schneider.
First, it's always nice to see someone hiring in this economy.
Second, the company confirmed the addition of Schneider is part of a broader plan to raise a Series B round later this year. Nerites was among the handful of companies we considered for our Series A Deals of the Year featured in last month's Start-Up. The company earned a mention in the article (find it here) but didn't make the final list, but we still care.
Third, we're going to get to hear the company's entire story at our upcoming IN3 West conference in Las Vegas.
Nerites will be among 50+ of the industry's choice start-ups presenting to a collection of biz dev and VC folks hoping to place the best bets (or best buys) in this tricky environment.
And those folks will give as well as take. The conference agenda includes discussions with senior level VCs from blue chip venture firms Frazier Healthcare Ventures, New Leaf Venture Partners, Versant Ventures and MedVenture Associates as well as seasoned medical device executives who have weathered some tough times in this industry.
And the fourth, final and probably least important (to you) reason we're excited: writing this blog post reminds us that IN VIVO Blog will be escaping the frigid East Coast for Vegas in just a few short weeks.
Hope to see you in Vegas!
3 comments:
David Snyder (not Schneider) was CFO of Nimblegen.
Thanks. Actually, the release from Nimblegen (and the VentureWire article) says David Sneider. http://www.cnbc.com/id/29035319
Apologies for the misspelling.
And I did just confirm with Nerites that they hired Dave Sneider, not Dave Snyder. But both men do exist.
Post a Comment